title: Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?
authors: School of Medicine, University of California, San Francisco (UCSF), 505 Parnassus Ave., San Francisco, CA, 94143, USA.
authors: Anna L
authors: AL
authors: Parks
authors: Ryan M
authors: RM
authors: McWhirter
authors: Kimberley
authors: K
authors: Evason
authors: Robin K
authors: RK
authors: Kelley
mesh_terms: D000368:Aged; D001650:Bile Duct Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000556:secondary / Q000628:therapy; D018281:Cholangiocarcinoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy; D008113:Liver Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009365:Neoplasm Regression, Spontaneous / Q000276:immunology* / Q000473:pathology; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies